MPM Oncology Impact Management »

Kalvista Pharmaceuticals shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $10M 882k 11.78
2024-03-31 $9.0M 761k 11.86
2023-09-30 $5.6M 578k 9.63
2023-06-30 $6.9M 762k 9.00

More positions owned by MPM Oncology Impact Management

Cullinan Therapeutics Common (CGEM)
Insmed Incorporated Common (INSM)
Olema Pharmaceuticals Common (OLMA)
iTeos Therapeutics Common (ITOS)
Crinetics Pharmaceuticals Common (CRNX)
Madrigal Pharmaceuticals Common (MDGL)
Iovance Biotherapeutics Common (IOVA)
Natera Common (NTRA)
Mirum Pharmaceuticals Common (MIRM)
Ultragenyx Pharmaceutical Common (RARE)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Guardant Health Common (GH)
Disc Medicine Common (IRON)
Alkermes Common (ALKS)
Edgewise Therapeutics Common (EWTX)

View all positions for MPM Oncology Impact Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Tang Capital Management
Suvretta Capital Management
Vestal Point Capital
Frazier Life Sciences Management
Capital World Investors
BlackRock
BlackRock
Vanguard Group
Boxer Capital
Dr. Jeffrey R. Jay, M.D.
Saturn V Capital Management
MPM Oncology Impact Management
Emerald Advisers
Geode Capital Management

View all funds holding Kalvista Pharmaceuticals